Katja Grosse-Sender

Title: Katja Grosse-Sender: Innovator in Pharmaceutical Formulations

Introduction

Katja Grosse-Sender is a notable inventor based in Kaiseraugst, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Her latest patents focus on the polymorphic forms of a specific compound, [5-fluoro-3-({2-[(4-fluorobenzene)sulfonyl]pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acid. The first patent describes a polymorphic form that is stable at room temperature, making it useful for preparing stable pharmaceutical formulations. The second patent highlights a polymorphic form that exhibits higher solubility than other forms, further enhancing its utility in pharmaceutical applications.

Career Highlights

Throughout her career, Katja has worked with prominent companies in the pharmaceutical industry. Notable among these are Atopix Therapeutics Limited and Chiesi Farmaceutici S.p.a. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.

Collaborations

One of her notable collaborators is Rolf Hilfiker, with whom she has worked on various projects in the pharmaceutical sector.

Conclusion

Katja Grosse-Sender's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a significant inventor. Her work continues to influence the development of stable and effective pharmaceutical formulations.